SEC Form 4 · accession 0000911916-18-000127
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katarzyna Mazur-Hofsaess
Officer — Pres., Eur., M. East & Afr.
Period of report
May 22, 2018
Accepted (ET)
May 23, 2018 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2018 | M | 8,765 | $73.15 | A | 25,447 | D | |
| Common StockF1 | May 22, 2018 | S | 8,765 | $113.6104 | D | 16,682 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $73.15 | May 22, 2018 | M | 8,765 | D | — | Mar 18, 2023 | Common Stock | 8,765 | 0 | D |
Explanation of responses
- F1Represents the sale of 8,765 shares in multiple transactions ranging in price from $113.30 to $114.14 per share, resulting in a weighted average sale price of $113.6104. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F2Vested annually over four years in increments of 25% each year, commencing on March 18, 2014.